
FDA approves new blue food dye derived from gardenia fruit
The color is approved for use in sports drinks, flavored or enhanced non-carbonated water, fruit drinks, ready-to-drink teas as well as hard and soft candy.
Petitioned by the Gardenia Blue Interest Group, the additive is made by refining the compound genipin — derived from crushed Gardenia jasminoides Ellis fruit, which is often used in traditional Chinese medicine — by reacting it with soy protein hydrolysate.
Though soy, a potential allergen, is used to make gardenia blue, the group has asked the FDA to exempt it from having to declare it as such. In its request, it says the soy protein is not expected to be detected in the final color additive and therefore will not cause allergic reactions. The FDA says it is still reviewing the request.
"Every day, children are exposed to synthetic chemicals in food that serve no purpose and threaten their health," Health Secretary Robert F. Kennedy Jr. said in a news release. "The FDA's approval of gardenia blue shows we're finally putting kids first. Thanks to Dr. Marty Makary's bold leadership, we're cutting through industry influence and taking decisive action to Make America Healthy Again."
The FDA says this marks the fourth color derived from natural sources approved by the administration for use in foods in the last two months.
In May, three other colors were approved, including galdieria extract blue, calcium phosphate (white) and butterfly pea flower extract (blues, purples and greens).
Kennedy previously called on companies to phase out all petroleum-based dyes by the end of next year, with the goal to replace them with natural alternatives in the U.S. food supply.
The food dye industry has denied any safety concerns with artificial dyes. The International Association of Color Manufacturers said in a statement after Kennedy's initial announcement that artificial dyes are "essential for consistency, visual appeal, and consumer trust in food products."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Wall Street Journal
9 minutes ago
- Wall Street Journal
Bill Gates: U.S. Aid for Global Health Is Saving Lives
When I was running Microsoft, we sometimes had to make difficult changes to our business. One key to our long-term success was that every time we decided to pivot, we studied the evidence to pinpoint what wasn't working and needed to shift—but also what was working and needed to be preserved. The Senate is about to consider a rescission bill that would eliminate more than $8 billion in lifesaving foreign aid, including nearly $1 billion in direct aid for global health programs, on top of the billions in such aid that has already been canceled. I'm alarmed at how a bid to eliminate inefficiencies in the U.S. budget—an important task—has put us on the verge of cutting funds for almost every single effective lifesaving aid program and, with it, our country's proud history of helping others less fortunate than ourselves. The proposal to cut this aid passed the House last month, and the Senate is expected to vote this week. Before senators decide to cut funds for global health programs, they should understand what this spending is, what it isn't, and all the U.S. has gained from it. I have now been working in global health for almost as long as I worked at Microsoft. The Gates Foundation has spent more than $100 billion, and I am as committed to excellence in this work as I was to Microsoft's. In global health, that means saving as many people's lives as possible for every dollar we spend on medicines or vaccines. That requires tracking and analyzing results closely, asking tough questions of my team, and seeing the work in action. I've been following the political debate over aid in the U.S., and there are three facts about health aid that keep getting lost in the back and forth.


Bloomberg
20 minutes ago
- Bloomberg
RFK Jr. Vows to Halt ‘Attack' on Fats in Whole Milk and Cheese
Health and Human Services Secretary Robert F. Kennedy Jr. and other top public health officials said Monday that saturated fats, long blamed for increased risk of heart disease, have been unfairly demonized by the medical community, indicating a pivot on government health guidelines is taking shape. 'There's a tremendous amount of emerging science that talks about the need for more protein in our diets, more fats in our diets,' Kennedy said Monday at a US Department of Agriculture event.


Fox News
21 minutes ago
- Fox News
Men face double dementia risk if they have a hidden genetic mutation
A hidden genetic mutation could predict a man's likelihood of developing dementia. That's according to an Australian study led by Monash and Curtin Universities, which analyzed the medical data of thousands of Australians and Americans. Men who had a certain variant in the haemochromatosis (HFE) gene — which regulates iron levels in the body — were found to be at a higher risk of dementia, the researchers found. Previously healthy men over age 70 who have two copies of the variant, which is known as H63D, are at least twice — or up to four times — as likely to develop dementia. Having just one copy did not appear to elevate the risk. One in 36 men carry two copies of the mutation; one in three have just a single copy. "It is only men who have two copies of the variant that are at risk," study co-author Professor John Olynyk from the Curtin Medical School told Fox News Digital. "Women are not affected by the abnormality – we do not know why that is at the current point in time." The study, which was published in the journal Neurology, used data from the ASPirin in Reducing Events in the Elderly (ASPREE) trial, which gathered health and aging data for 19,114 healthy older adults. Those who have the genetic variant can't change it, but it's possible that the "brain pathways" it affects could be treated, Olynyk noted. "The HFE gene is routinely tested for in most Western countries … when assessing people for haemochromatosis, a disorder that causes the body to absorb too much iron," the doctor said. "Our findings suggest that perhaps this testing could be offered to men more broadly." Despite the fact that the HFE gene is responsible for controlling iron levels, the team found no direct link between iron and dementia risk. "Our findings suggest that perhaps this testing could be offered to men more broadly." "This points to other mechanisms at play, possibly involving the increased risk of brain injury from inflammation and cell damage in the body," Olynyk added. More research is needed to determine why the heightened risk wasn't seen in women. "Understanding why men with the double H63D variant are at higher risk could pave the way for more personalized approaches to prevention and treatment," added co-author Professor Paul Lacaze from Monash University in a press release. The main limitation of the study, according to Olynyk, was that the study population was largely composed of Australians. "Whether other populations exhibit the same effects is unclear," he told Fox News Digital. "Our work should be repeated in different countries to assess this." "Further research will be undertaken to try and determine the likely mechanism by which this anomaly causes dementia and what more we can do to reduce the impact of it." Beyond this specific mutation, many other genetic and environmental factors can contribute to dementia risk, Olynyk noted. "While genetic risk factors cannot be changed, the mechanisms by which these genetic abnormalities and environmental factors cause disease may well be modifiable to some extent, through adopting a healthy lifestyle and being proactive about maintaining an overall good state of health," he said. To reduce risk, the researchers recommend adopting a healthy lifestyle that includes exercising regularly, eating a nutritious diet, minimizing alcohol intake, remaining mentally active, and seeing a doctor to address any medical problem known to increase the likelihood of dementia. For more Health articles, visit The University of Melbourne, The Royal Children's Hospital, Murdoch Children's Research Institute and Fiona Stanley Hospital also contributed to the study.